11.11.2015 • News

Brazil’s Oxiteno Adds Alkoxylation Capacity in US

Brazilian specialty chemical and surfactants company Oxiteno is building an alkoxylation unit in Pasadena, Texas, USA, to meet growing demand from the North American market.

The plant, which will have a capacity of 170,000 t/y, is expected to start operations in the fourth quarter of 2017. Oxiteno said the expansion is part of its ongoing strategy of investing in the Americas. Since 2003, the company has acquired plants in Mexico, Venezuela and Uruguay, and opened its first commercial office in the US.

CEO João Parolin said the company is also expanding its commercial and technical services as well as its local R&D structure. He added that distribution centers will be available to serve all US regions.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read